Isabel Guedes-Guedes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabel Guedes-Guedes has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Gonzalez-Hernandez
Instrumentacion y Oftalmologia, INSOFT S.L., 38004 Santa Cruz de Tenerife, Spain
2 shared publications - Manuel Gonzalez de la Rosa
Faculty of Medicine, University of La Laguna, La Laguna
2 shared publications - Marta Gonzalez-Hernandez
Department of Ophthalmology, University Hospital of the Canary Islands, University of La Laguna, La Laguna, Spain
2 shared publications - Nisamar Betancor-Caro
Hospital Universitario de Canarias, 38320 La Laguna, Spain
2 shared publications - Alicia Pareja-Ríos
Hospital Universitario de Canarias, La Laguna, Tenerife, España
1 shared publication Ayoze González Hernández
Neurology, Hospital Universitario de Gran Canaria Doctor Negrín, Fernando Pessoa University, Las Palmas de Gran Canaria, Spain
1 shared publication
Latest Publications
- Open Access
- 19 November 2025
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 11 (1) , 125
Evaluation of the degree of agreement in the diagnosis of diabetic retinopathy between ophthalmologists and EyeArt®
Objective or purpose: To evaluate the diagnostic performance and agreement of the EyeArt ® Artificial Intelligence (AI) system for detecting Diabetic Retinopathy (DR), comparing its results with ophthalmologists’ assessments in a regional screening program. Design: Cross-sectional observational study. Subjects, participants, and/or controls: A total of 498 diabetic patients aged 18 years or older were enrolled between June and September 2023 through the Retisalud DR screening program in the Canary Islands. No separate control group was included. Methods: All participants underwent non-mydriatic fundus photography using the TRC-NW400 camera. Retinal images were analyzed by the EyeArt ® AI system (version 2.1.0), and results were compared with assessments by ophthalmologists based on the International Clinical Diabetic Retinopathy scale (ICDR). Agreement was quantified using Cohen’s kappa coefficient. Additionally, mixed-effects logistic regression was used to explore associations between DR and clinical risk factors. Main outcome measures: Sensitivity, specificity, and agreement (Cohen’s kappa) of the AI system compared to clinical diagnosis; predictors of DR such as age, diabetes duration, presence of Diabetic Macular Edema (DME), and central retinal thickness (CRT-OCT). Results: The EyeArt® system achieved a binocular sensitivity of 100% (95% CI: 98.1–100) and a specificity of 93.5% (95% CI: 90.2–96.0). Agreement with ophthalmologist grading was excellent, with kappa values of 0.966 (right eye) and 0.978 (left eye). Younger age, longer diabetes duration, DME presence, and higher CRT were significantly associated with DR diagnosis. Conclusions: The EyeArt ® AI system showed excellent diagnostic accuracy and strong agreement with clinical evaluations in DR screening. Nonetheless, its tendency to overestimate DR severity indicates the need for further refinement of its grading algorithm. These findings support the potential integration of AI systems into large-scale DR screening programs, pending further validation.
- 19 November 2025
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 11 (1) , 125
Open AccessEvaluation of the degree of agreement in the diagnosis of diabetic retinopathy between ophthalmologists and EyeArt®
Objective or purpose: To evaluate the diagnostic performance and agreement of the EyeArt ® Artificial Intelligence (AI) system for detecting Diabetic Retinopathy (DR), comparing its results with ophthalmologists’ assessments in a regional screening program. Design: Cross-sectional observational study. Subjects, participants, and/or controls: A total of 498 diabetic patients aged 18 years or older were enrolled between June and September 2023 through the Retisalud DR screening program in the Canary Islands. No separate control group was included. Methods: All participants underwent non-mydriatic fundus photography using the TRC-NW400 camera. Retinal images were analyzed by the EyeArt ® AI system (version 2.1.0), and results were compared with assessments by ophthalmologists based on the International Clinical Diabetic Retinopathy scale (ICDR). Agreement was quantified using Cohen’s kappa coefficient. Additionally, mixed-effects logistic regression was used to explore associations between DR and clinical risk factors. Main outcome measures: Sensitivity, specificity, and agreement (Cohen’s kappa) of the AI system compared to clinical diagnosis; predictors of DR such as age, diabetes duration, presence of Diabetic Macular Edema (DME), and central retinal thickness (CRT-OCT). Results: The EyeArt® system achieved a binocular sensitivity of 100% (95% CI: 98.1–100) and a specificity of 93.5% (95% CI: 90.2–96.0). Agreement with ophthalmologist grading was excellent, with kappa values of 0.966 (right eye) and 0.978 (left eye). Younger age, longer diabetes duration, DME presence, and higher CRT were significantly associated with DR diagnosis. Conclusions: The EyeArt ® AI system showed excellent diagnostic accuracy and strong agreement with clinical evaluations in DR screening. Nonetheless, its tendency to overestimate DR severity indicates the need for further refinement of its grading algorithm. These findings support the potential integration of AI systems into large-scale DR screening programs, pending further validation.
- 31 January 2025
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología (English Edition)
- Vol. 100 (4) , 185-190
Etiology of infectious keratitis
- 31 January 2025
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología (English Edition)
- Vol. 100 (4) , 185-190
Etiology of infectious keratitis
- Open Access
- 10 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (18) , 5876
Identification of Glaucoma in Diabetics Using the Laguna-ONhE Colourimetric Method and OCT Spectralis
Background: Previous retrospective results are evaluated prospectively and blinded. Methods: A total of 221 eyes previously classified as normal (G1), 279 as moderate risk of glaucoma (G2) and 217 as high risk (G3) according to the Globin Discriminant Function (GDF) Laguna-ONhE index were examined with OCT Spectralis- Results: In G1, the Bruch’s Membrane Opening Minimum Rim Width (BMO-MRW) was 332 ± 55 microns; in G2, it was 252 ± 47 (p < 0.0001); and in G3, 231 ± 44 (p < 0.0001). In G1, the 1% and 5% percentiles were 233 and 248, respectively; in G2, they were lower in 28.80% and 42.29% of cases, respectively; and in G3, in 50.23% and 63.59% of cases, respectively. Most of the cases were normal-tension glaucomas. Laguna-ONhE indices showed a curvilinear correlation with BMO-MRW results. The Retinal Nerve Fibre Layer (RNFL) showed a poor relationship with BMO. Assuming G1 to be truly normal, BMO-MRW would have a Receiver operating characteristic (ROC) curve area of 0.901 for G2 and G3 and 0.651 for RNFL. A significant reduction in pixels corresponding to vessels was found in G2 and G3 vs. G1 (p < 0.0001). Conclusions: In some cases, these defects appear to be mainly glaucomatous, and in others, they are associated with diabetic microangiopathy. In normal tension glaucoma, RNFL defects may be less severe than those inside the nerve.
- 10 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (18) , 5876
Open AccessIdentification of Glaucoma in Diabetics Using the Laguna-ONhE Colourimetric Method and OCT Spectralis
Background: Previous retrospective results are evaluated prospectively and blinded. Methods: A total of 221 eyes previously classified as normal (G1), 279 as moderate risk of glaucoma (G2) and 217 as high risk (G3) according to the Globin Discriminant Function (GDF) Laguna-ONhE index were examined with OCT Spectralis- Results: In G1, the Bruch’s Membrane Opening Minimum Rim Width (BMO-MRW) was 332 ± 55 microns; in G2, it was 252 ± 47 (p < 0.0001); and in G3, 231 ± 44 (p < 0.0001). In G1, the 1% and 5% percentiles were 233 and 248, respectively; in G2, they were lower in 28.80% and 42.29% of cases, respectively; and in G3, in 50.23% and 63.59% of cases, respectively. Most of the cases were normal-tension glaucomas. Laguna-ONhE indices showed a curvilinear correlation with BMO-MRW results. The Retinal Nerve Fibre Layer (RNFL) showed a poor relationship with BMO. Assuming G1 to be truly normal, BMO-MRW would have a Receiver operating characteristic (ROC) curve area of 0.901 for G2 and G3 and 0.651 for RNFL. A significant reduction in pixels corresponding to vessels was found in G2 and G3 vs. G1 (p < 0.0001). Conclusions: In some cases, these defects appear to be mainly glaucomatous, and in others, they are associated with diabetic microangiopathy. In normal tension glaucoma, RNFL defects may be less severe than those inside the nerve.
- Open Access
- 8 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7294
Glaucoma Incidence and Progression in Diabetics: The Canary Islands Study Using the Laguna ONhE Application
Background: Laguna ONhE provides a globin distribution function (GDF), in which a glaucoma discriminator based on deep learning plays an important role, and there is also an optimized globin individual pointer (GIP) for progression analysis. Methods: Signs of optic nerve glaucoma were identified in 1,124,885 fundus images from 203,115 diabetics obtained over 15 years and 117,813 control images. Results: A total of 743,696 images from 313,040 eyes of 173,661 diabetics were analysed. Some exclusions occurred due to excessive illumination, poor quality, or the absence of optic discs. Suspicion of glaucoma was reported in 6.70%, for an intended specificity of 99% (GDF < −15). More signs of glaucoma occur in diabetics as their years of disease increase, and after age 60, compared to controls. The GIP detected progression (p < 0.01) in 2.59% of cases with 4 controls and in 42.6% with 14 controls was higher in cases with lower GDF values. The GDF was corrected for the disc area and proved to be independent of it (r = 0.001925; p = 0.2814). Conclusions: The GDF index suggests a higher and increasing glaucoma probability in diabetics over time. Doubling the number of check-ups from four to eight increases the ability to detect GIP index progression by a factor of 5.
- 8 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7294
Open AccessGlaucoma Incidence and Progression in Diabetics: The Canary Islands Study Using the Laguna ONhE Application
Background: Laguna ONhE provides a globin distribution function (GDF), in which a glaucoma discriminator based on deep learning plays an important role, and there is also an optimized globin individual pointer (GIP) for progression analysis. Methods: Signs of optic nerve glaucoma were identified in 1,124,885 fundus images from 203,115 diabetics obtained over 15 years and 117,813 control images. Results: A total of 743,696 images from 313,040 eyes of 173,661 diabetics were analysed. Some exclusions occurred due to excessive illumination, poor quality, or the absence of optic discs. Suspicion of glaucoma was reported in 6.70%, for an intended specificity of 99% (GDF < −15). More signs of glaucoma occur in diabetics as their years of disease increase, and after age 60, compared to controls. The GIP detected progression (p < 0.01) in 2.59% of cases with 4 controls and in 42.6% with 14 controls was higher in cases with lower GDF values. The GDF was corrected for the disc area and proved to be independent of it (r = 0.001925; p = 0.2814). Conclusions: The GDF index suggests a higher and increasing glaucoma probability in diabetics over time. Doubling the number of check-ups from four to eight increases the ability to detect GIP index progression by a factor of 5.